RESUMO
Three case reports of Cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropositive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortality. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection.
Assuntos
Infecção Hospitalar/transmissão , Infecções por Citomegalovirus/transmissão , Transplante de Rim/efeitos adversos , Adolescente , Adulto , Infecção Hospitalar/sangue , Infecção Hospitalar/tratamento farmacológico , Infecções por Citomegalovirus/sangue , Infecções por Citomegalovirus/tratamento farmacológico , Diagnóstico Diferencial , Feminino , Ganciclovir/uso terapêutico , Humanos , MasculinoRESUMO
Three case reports of cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropositive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortalitiy. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection (AU)
Assuntos
Relatos de Casos , Humanos , Masculino , Feminino , Adolescente , Adulto , Transplante de Rim/efeitos adversos , Infecções por Citomegalovirus/complicações , Infecções por Citomegalovirus/tratamento farmacológico , Terapia de Imunossupressão/efeitos adversos , Rejeição de EnxertoRESUMO
Three case reports of cytomegalovirus (CMV) disease in seronegative renal transplant recipients of seropossitive donor kidneys are presented. Clinicians need to have a high index of suspicion for CMV disease in such patients. Early diagnosis and treatment are essential to decrease morbidity and mortalitiy. Prophylaxis with antiviral and/or CMV-hyperimmunoglobulin may decrease the incidence of serious infection